SANUWAVE, Inc., a Georgia based company, is specializing in the development and commercialization of non-invasive, biological response activating devices for the repair and regeneration of tissue, musculoskeletal, and vascular structures. Their lead product candidate, called dermaPACE®, utilizes high energy acoustic pressure waves to treat chronic wounds, effectively enhancing the body’s own healing process. Most recently, the non-invasive device was shown to significantly decrease the size of diabetic foot ulcers, confirming just one of many markets to which the technology is expected to be applied.
The proprietary technology is now being developed for treating a wide range of diverse conditions, including burns, wounds, skin eruptions, cellulite treatment, orthopedic/spine applications, improving bone density in osteoporosis, eliminating chronic pain from trauma and arthritis, blood flow stimulation, and possibly even removing plaque due to atherosclerosis. Treatment does not require anesthesia, is quick and easy to administer, and is highly cost effective.
It’s all based upon acoustic pressure waves delivered in the shock-wave acoustic spectrum, a form that results in revascularization and microcirculatory improvement in musculoskeletal and soft tissue, which in turn promotes tissue regeneration. The unique shock waves used in PACE (Pulsed Acoustic Cellular Expression) technology are different from other familiar forms of acoustic energy, such as ultrasound. With PACE, the generated acoustic wave front represents a region of sudden and forceful change in stress, density, and temperature. It’s these shock waves that have been discovered to have a dramatic effect on living cells, and it’s this technology that SANUWAVE plans to ride into the future.
For additional information, visit the company’s website at www.SANUWAVE.com
About MissionIR:
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
